Self-sampling for cervical cancer screening – what is it and what does evidence from Europe tell us about whether it provides any benefits compared to traditional ways of screening?
Regular screening is crucial for preventing cervical cancer or identifying cancer at an early stage, when treatment is most likely to be successful. Screening is particularly important for women who did not receive the HPV vaccine; in the UK, that means most women over the age of 30. Many European countries, including the UK, have Read More >
Prescribing restrictions for triple therapy in COPD
We are pleased to announce that our study, exploring barriers to accessing triple therapy for COPD management in primary care across Europe, was presented at the 12th International Care Respiratory Group (IPCRG) World Conference in Athens. The research looked at the variation in the pharmacological management of COPD due to payer-driven access criteria for triple Read More >
COPD care: different countries, same issues
Chronic Obstructive Pulmonary Disease (COPD) persists as a major global public health issue demanding urgent attention from policymakers. Despite being preventable and treatable, COPD is the third leading cause of death globally* accounting for 3.3 million deaths worldwide. Aquarius Population Health conducted a qualitative research study with 17 clinical experts involved in COPD management from Read More >
Comparing the costs and diagnostic outcomes of using DNA methylation testing instead of liquid-based cytology within HPV primary cervical cancer screening in the Netherlands.
Publication of our research assessing the potential health and economic benefits of improved management of chronic obstructive pulmonary disease in England, Germany, Canada, and Japan.
Publication of our economic evaluation comparing two cervical screening strategies in Belgium: HPV primary versus co-testing
Publication of our work evaluating how seizure-free days are related with other quality of life predictors for patients with Dravet Syndrome and their carers.
An economic evaluation of two PCR-based respiratory panel assays for patients admitted to hospital with community-acquired pneumonia (CAP) in the UK, France, and Spain
Improving the NHS Blood Culture Pathway in England
Bloodstream infections (BSI) are common and cause severe disease and death. Blood cultures are used to identify whether patients have a bacterial or fungal BSI and assess whether the microbe will be resistant to any antimicrobial therapies (AMTs) helping clinicians to prescribe AMTs to patients who truly need them. NHS England’s blood culture audit indicated low adherence to best practice guidelines and trusts have raised concerns regarding the resource implications of achieving compliance.